Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source
IoT Authentication in Federated Learning: Methods, Challenges, and Future Directions. [PDF]
Badhib A, Alshehri S, Cherif A.
europepmc +1 more source
TBK1‐Associated Primary Lateral Sclerosis Followed by Right Temporal Variant Frontotemporal Dementia
ABSTRACT We report a 58‐year‐old woman with a novel splice‐site variant in the TANK‐binding kinase 1 (TBK1:c.993–2A>C p.Ala332TyrfsTer39) who sequentially developed primary lateral sclerosis (PLS) followed by right temporal variant frontotemporal dementia (rtvFTD). Neuroimaging demonstrated right anterior temporal atrophy before cognitive symptoms, and
Tomoyasu Matsubara +18 more
wiley +1 more source
A secure and efficient user selection scheme in vehicular crowdsensing. [PDF]
Zhang M, Ye Q, Yuan Z, Deng K.
europepmc +1 more source
Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann +17 more
wiley +1 more source
A reflection on 'Aggregation-induced emission enhancement of a <i>meso</i>-trifluoromethyl BODIPY <i>via</i> J-aggregation': from fundamental discovery to versatile sensing platforms. [PDF]
Sharma P, Bouffard J, Kim Y.
europepmc +1 more source
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen +7 more
wiley +1 more source
Identity-based linear homomorphic signature for a restricted combiners' group for e-commerce. [PDF]
Tian Y +7 more
europepmc +1 more source
Pairing-Free Certificateless Aggregate Signatures for VANETs Revisited: A Survey of 64 Schemes with Universal Cryptanalysis [PDF]
Zhiyuan Sui +4 more
openalex +1 more source
A New Aggregate Signature Scheme in Cryptographic Currency [PDF]
openaire +1 more source

